Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160015/S020

AED Plus, AED 3, X Series, R Series, Propaq MD, AED Pro, AED 3 BLS

ZOLL MEDICAL CORPORATION · Decision date Aug 28, 2025

FDA DECISIONP160015/S020

What did the FDA approve?

FDA records P160015/S020 as a supplement to PMA P160015, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 28, 2025.

FDA approval order statement

approval for a manufacturing site located at ZOLL Medical, 38 Upton Drive, Wilmington, MA 01887
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Aug 28, 2025
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P160015/S020
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Aug 28, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160015. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160015 · Original PMA

    AED Plus and Fully Automatic AED Plus

  2. P160015/S020 received

    Application receipt date recorded by FDA.

  3. P160015/S024 · Related supplement

    AED Plus and Fully Automatic AED Plus

  4. P160015/S020 · FDA decision

    Normal 180 Day Track No User Fee

  5. P160015/S029 · Related supplement

    AED 3 Defibrillator with Uni-Padz

Timeline entries are records held by MedtechLedger for P160015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160015

Product / regulatory recordCompanyPathwayDecision dateSource
ZOLL MEDICAL CORPORATIONPMA approvalMay 26, 2017FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 24, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 22, 2025FDA
AED 3P160015/S025
ZOLL MEDICAL CORPORATIONPMA supplementDec 18, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 16, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementOct 16, 2026FDA

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ZOLL MEDICAL CORPORATION

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
269 & 271 Mill Rd., Chelsmford, MA, 01824

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records